Savara Inc Common Stock, Capital Shares Reserved for Future Issuance
Savara Inc (SVRA) had Common Stock, Capital Shares Reserved for Future Issuance of 67.88 million shares as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-11
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 67.88M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 68.35M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 68.83M shares.
- 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 61.00M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2026-06-30 | 67.88M shares 10-Q · filed 2026-08-11 |
| 2026-03-31 | 68.35M shares 10-Q · filed 2026-05-12 |
| 2025-12-31 | 68.83M shares 10-Q · filed 2026-08-11 |
| 2025-09-30 | 61.00M shares 10-Q · filed 2025-11-12 |
| 2025-06-30 | 60.93M shares 10-Q · filed 2025-08-13 |
| 2025-03-31 | 60.98M shares 10-Q · filed 2025-05-13 |
| 2024-12-31 | 61.93M shares 10-K · filed 2026-03-13 |
| 2024-09-30 | 57.71M shares 10-Q · filed 2024-11-12 |
| 2024-06-30 | 57.77M shares 10-Q · filed 2024-08-12 |
| 2024-03-31 | 57.90M shares 10-Q · filed 2024-05-09 |
| 2023-12-31 | 57.60M shares 10-K · filed 2025-03-27 |
| 2023-09-30 | 55.31M shares 10-Q · filed 2023-11-09 |
| 2023-06-30 | 49.73M shares 10-Q · filed 2023-08-10 |
| 2023-03-31 | 49.39M shares 10-Q · filed 2023-05-15 |
| 2022-12-31 | 48.68M shares 10-K · filed 2024-03-07 |
| 2022-09-30 | 45.75M shares 10-Q · filed 2022-11-10 |
| 2022-06-30 | 46.01M shares 10-Q · filed 2022-08-11 |
| 2022-03-31 | 46.28B shares 10-Q · filed 2022-05-11 |
| 2021-12-31 | 46.30M shares 10-K · filed 2023-03-30 |
| 2021-09-30 | 44.32M shares 10-Q · filed 2021-11-12 |
| 2021-06-30 | 47.77M shares 10-Q · filed 2021-08-12 |
| 2021-03-31 | 48.16M shares 10-Q · filed 2021-05-13 |
| 2020-12-31 | 45.13M shares 10-K · filed 2022-03-30 |
| 2020-09-30 | 43.58M shares 10-Q · filed 2020-11-05 |
| 2020-06-30 | 44.38M shares 10-Q · filed 2020-08-06 |
| 2020-03-31 | 44.46M shares 10-Q · filed 2020-05-07 |
| 2019-12-31 | 44.54M shares 10-K · filed 2021-03-10 |
| 2019-09-30 | 5.02M shares 10-Q · filed 2019-11-07 |
| 2019-06-30 | 5.07M shares 10-Q · filed 2019-08-08 |
| 2019-03-31 | 4.95M shares 10-Q · filed 2019-05-09 |
| 2018-12-31 | 4.91M shares 10-K · filed 2020-03-12 |
| 2018-09-30 | 4.47M shares 10-Q · filed 2018-11-07 |
| 2018-06-30 | 3.54M shares 10-Q · filed 2018-08-09 |
| 2018-03-31 | 4.05M shares 10-Q · filed 2018-05-09 |
| 2017-12-31 | 4.07M shares 10-K · filed 2019-03-13 |
| 2017-09-30 | 3.60M shares 10-Q · filed 2017-11-08 |
| 2017-06-30 | 3.04M shares 10-Q · filed 2017-08-09 |
| 2016-12-31 | 14.16M shares 10-K · filed 2018-03-14 |
| 2013-12-31 | 8.64M shares 10-Q · filed 2014-08-11 |
| 2012-12-31 | 8.64M shares 10-Q · filed 2014-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |